Full-Time

Senior Enterprise Account Executive

Life Sciences

Updated on 7/23/2026

Turquoise Health

Turquoise Health

51-200 employees

Healthcare price transparency platform for patients

Compensation Overview

$245k - $285k/yr

Remote in USA

Remote

Category
Sales & Account Management (1)
Required Skills
Lead Generation
Forecasting
Word/Pages/Docs
Marketing
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Turquoise Health

Find people who can refer or advise you

Requirements
  • 5+ years of Enterprise Life Sciences sales experience or 3+ years of management consulting experience within Life Sciences. Specific focus being market access, pricing and reimbursement space.
  • Strong ability to communicate value proposition to publicly traded Life Sciences stakeholders including Market Access, HEOR/RWE, Gov’t Affairs, Field Reimbursement, and Marketing, with an in depth knowledge of Life Sciences product pricing and commercialization strategies within US healthcare ecosystem
  • Effective communication, negotiation, and presentation skills with proven track record of meeting or exceeding sales targets
  • Strategic mind and process oriented with a high attention to detail and excellent organizational skills
  • Expert internal communicator and accountable team player
  • Self-starter and innate entrepreneurial agency and ability
  • Excellent organization & planning skills
  • Natural curiosity & problem solving skills
  • A passion for healthcare, Life Sciences data, and technology
  • Strong proficiency with Microsoft Office/G-Suite including (Powerpoint, Excel/Sheets, and Word/G Docs)
  • Bachelor’s degree or equivalent experience/knowledge. We are happy to work with strong candidates with non-traditional educational backgrounds
Responsibilities
  • Manage the full sales cycle from lead generation to closing net new business
  • Meet or exceed sales quota to drive education and adoption of our Life Sciences products and solutions to Pharma, Med Device, Lab Diagnostics, and DME manufacturers and suppliers.
  • Demonstrate subject matter expertise and effectively communicate the value within key target accounts in the Life Sciences space
  • Expand our Life Sciences business, assessing customer needs by selling appropriate Turquoise Health products to Market Access, HEOR/RWE, Gov’t Affairs, Pricing and Strategy teams across top Life Sciences companies in Pharma, Med Device, Lab Diagnostics, and DME manufacturers and suppliers.
  • Generate new business revenue with core ICP with the ability to expand account revenue and source upsell opportunities within customer accounts
  • Facilitate customer education around our key products and services with internal and external subject matter experts
  • Develop deep and meaningful relationships across all aspects of the customer organization from Managers through C-suite executives
  • Create and execute on account plans and stakeholder engagement strategy that result in net new customer acquisition and revenue expansion within key accounts
  • Build prospect and customer facing presentations and platform demonstrations
  • Run discovery and actively problem solve prospect ambiguous business challenges through our solution to create value that drives revenue for the business
  • Accuracy in forecasting and detailed pipeline management of accounts and quarterly revenue target
  • Work closely with Business Development, Customer Success, Solutions Engineering, and Marketing to execute GTM strategy at a high performing level
  • Represent Turquoise Health at industry events, conferences, in-person client meetings, and networking opportunities to enhance visibility with customers and prospects to strategically drive revenue
  • Drive cross-functional projects and initiatives that scales with departmental and organizational goals
  • Collaborate with leadership team to define and refine strategic objectives and long-term goals
  • Implement new data-driven strategies that scale sales processes and drive repeatable revenue for the business

Turquoise Health provides a digital platform that helps patients and healthcare providers compare healthcare costs by making hospital and health-plan prices transparent and easy to understand. The core product is a user-friendly interface that lets users enter insurance information and view estimated out-of-pocket costs for a wide range of services, from basic labs to procedures like tonsil removal and abdominal ultrasounds. The platform pulls pricing data required by law to be publicly available and presents it in a clear, searchable format, enabling cost comparisons across providers and plans. Unlike some competitors, Turquoise Health’s differentiator is its focus on consolidating and displaying publicly available price data from multiple providers and insurers to empower informed decisions about care and costs. The company’s goal is to help patients navigate the opaque pricing landscape in healthcare and promote price transparency by making price information widely accessible.

Company Size

51-200

Company Stage

Series C

Total Funding

$95.3M

Headquarters

San Diego, California

Founded

2020

Get referred to Turquoise Health

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • $40M Series C led by Oak HC/FT fuels go-to-market expansion.
  • Serves 280+ customers including 10 top-25 health systems.
  • Team grows to nearly 200 with enterprise-grade security.

What critics are saying

  • CMS fines exceed $100M since 2024, hospitals reach compliance.
  • CareJourney commoditizes MRF data with free public datasets.
  • Price convergence drops high rates 6.3% annually, flattens variations.

What makes Turquoise Health unique

  • Clear Rates synthesizes pricing signals into auditable payer-provider rates.
  • Contracts uses AI to transform documents into searchable portfolios.
  • AskTQ reduces manual research from weeks to seconds instantly.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

401(k) Retirement Plan

401(k) Company Match

Remote Work Options

Flexible Work Hours

Home Office Stipend

Phone/Internet Stipend

Professional Development Budget

Parental Leave

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-6%

2 year growth

-1%
Business Wire
Mar 18th, 2026
Turquoise Health Announces $40 Million Series C to Become the Operating System for Healthcare Contracts and Payments

Turquoise Health (“Turquoise”), a multi-sided healthcare pricing and payment platform, today announced it has raised $40 million in Series C funding. The rou...

Sahyadri Startups
Mar 17th, 2026
Turquoise Health raises $40M Series C led by Oak HC/FT to fix healthcare pricing opacity

Turquoise Health, a healthcare pricing and payment platform, has raised $40 million in Series C funding led by Oak HC/FT, with participation from Andreessen Horowitz, Adams Street Partners and Yosemite. The San Diego-based company addresses healthcare's administrative complexity by centralising contract data and pricing information. Its platform combines Clear Rates, which synthesises pricing signals into auditable rates for payer-provider combinations, and Contracts, which uses AI to transform static documents into searchable contract portfolios. The system includes AskTQ, an AI-powered layer that reduces manual research from weeks to seconds. Turquoise Health serves over 280 customers, including 10 of the top 25 health systems and four of the five national payers. The funding will support go-to-market efforts and expand its nearly 200-person team.

PR Newswire
Jul 9th, 2024
Patientrightsadvocate.Org Statement On Turquoise Health'S Mrf Tracker

WASHINGTON, July 9, 2024 /PRNewswire/ -- Today, PatientRightsAdvocate.org (PRA) released a statement on the findings of the new machine-readable file (MRF) tracker by Turquoise Health that tracks real-time hospital compliance with the federal hospital price transparency rule."We applaud Turquoise Health for creating a live tracker showing hospital compliance with the Hospital Price Transparency Rule. Unfortunately, much like our semi-annual compliance reports, their data show alarmingly low rates of full compliance with the hospital price transparency requirements," said PatientRightsAdvocate.org Founder and Chairman Cynthia Fisher. "Despite the rules being in effect for more than three years, all healthcare consumers are harmed by a lack of access to real upfront prices. With three-quarters of hospitals failing to pass CMS's validator tool, which by their admission does not constitute compliance with transparency requirements, it is clear that lackluster enforcement of hospital price transparency rules by CMS has enabled hospitals to maintain unacceptably low rates of compliance. Increased enforcement, including fines, and the passage of robust legislation to codify and strengthen these rules are necessary to bring more hospitals into full compliance and protect patients from overcharges, errors, and even fraud in medical billing."Background:According to the Turquoise tracker, only 16.7% of hospitals nationwide comply with the latest form and structure requirements that pass the CMS validator tool (which does not assess the accuracy of the data) and post a compliant text file. Of the MRFs analyzed by Turquoise, half post the data necessary to be considered fully compliant with the price transparency rules.PRA's sixth Semi-Annual Hospital Price Transparency Compliance Report revealed just 34.5% of hospitals surveyed were in full compliance with the federal hospital price transparency rule

PYMNTS
May 16th, 2024
Steep Hospital Costs Help Inflation Persist

American medical care costs have gone up, and that’s reportedly helped inflation remain high.Hospital prices climbed 7.7% between April 2023 and April 2024, the biggest monthly increase since October 2010, The Wall Street Journal (WSJ) reported Thursday (May 16), citing data from the U.S. Department of Labor.The report also included an analysis — performed for the WSJ by Turquoise Health — of recent price increases for specific procedures helping fuel this trend.For example, the cost of performing an angioplasty on cardiac patients grew $670, or 4.5%, to $15,640 in the first squatter of the year, the report said. Intensive care for newborns now costs as much as $7,939 per day, a 5% increase. And breast biopsies performed with a needle rose $220 during the period, or 4.6%, to $5,027.The first wave of inflation missed hospitals, as their prices were already set by contracts with health insurers, according to the report. However, inflation has begun to take hold as these healthcare providers have renegotiated prices. The reason: Hospitals need to pay for rising wages, with hiring in the health sector remaining robust.Economists said they expect this trend to stick around as upheaval in the labor market continues to affect wages and health insurance contracts, per the report.“We’re not expecting much slowing,” said Alan Detmeister, an economist for UBS

Pulse 2.0
Jan 26th, 2024
Turquoise Health: Healthcare Pricing Company Secures $30 Million

Turquoise Health - an end-to-end healthcare pricing platform - has announced a $30 million Series B investment led by Adams Street Partners, with participation from Yosemite and existing investors Andreessen Horowitz and BoxGroup.